Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood
Clinical trial NCT02306629 · COMPLETED
Trial details
- NCT number
- NCT02306629
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.